BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li W, Zeng S, Yu LS, Zhou Q. Pharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management. Ther Clin Risk Manag 2013;9:259-71. [PMID: 23745048 DOI: 10.2147/TCRM.S43151] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lan MJ, Zhou Q. Potential therapeutic hazards due to drug-drug interaction between topically and systemically coadministered medications. Ther Clin Risk Manag 2013;9:313-7. [PMID: 23986640 DOI: 10.2147/TCRM.S50375] [Reference Citation Analysis]
2 Kroon S, Snijder RJ, Hosman AE, Vorselaars VMM, Disch FJM, Post MC, Mager JJ. Oral itraconazole for epistaxis in hereditary hemorrhagic telangiectasia: a proof of concept study. Angiogenesis 2021;24:379-86. [PMID: 33211216 DOI: 10.1007/s10456-020-09758-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Abdi S, Sargashteh Z, Abbasinazari M, Salamzadeh J, Mortazavi SA. Buccal Buspirone as add-on Therapy to Omeprazole Versus Omeprazole in Treatment of Gastroesophageal Reflux Diseases (GERD). Iran J Pharm Res 2020;19:113-20. [PMID: 33841527 DOI: 10.22037/ijpr.2020.113320.14231] [Reference Citation Analysis]
4 Ortiz-Guerrero G, Amador-Muñoz D, Calderón-Ospina CA, López-Fuentes D, Nava Mesa MO. Proton Pump Inhibitors and Dementia: Physiopathological Mechanisms and Clinical Consequences. Neural Plast 2018;2018:5257285. [PMID: 29755512 DOI: 10.1155/2018/5257285] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
5 Filler G, Alvarez-Elías AC, McIntyre C, Medeiros M. The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy. Pediatr Nephrol 2017;32:21-9. [PMID: 26921212 DOI: 10.1007/s00467-016-3352-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
6 Papotti B, Marchi C, Adorni MP, Potì F. Drug-drug interactions in polypharmacy patients: The impact of renal impairment. Curr Res Pharmacol Drug Discov 2021;2:100020. [PMID: 34909655 DOI: 10.1016/j.crphar.2021.100020] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Feng XQ, Zhu LL, Zhou Q. Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management. J Pain Res 2017;10:1225-39. [PMID: 28579821 DOI: 10.2147/JPR.S138698] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 4.4] [Reference Citation Analysis]
8 Zhang XL, Chen M, Zhu LL, Zhou Q. Therapeutic Risk and Benefits of Concomitantly Using Herbal Medicines and Conventional Medicines: From the Perspectives of Evidence Based on Randomized Controlled Trials and Clinical Risk Management. Evid Based Complement Alternat Med 2017;2017:9296404. [PMID: 28491115 DOI: 10.1155/2017/9296404] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Soares GA, Pires DW, Pinto LA, Rodrigues GS, Prospero AG, Biasotti GGA, Bittencourt GN, Stoppa EG, Corá LA, Oliveira RB, Miranda JRA. The Influence of Omeprazole on the Dissolution Processes of pH-Dependent Magnetic Tablets Assessed by Pharmacomagnetography. Pharmaceutics 2021;13:1274. [PMID: 34452233 DOI: 10.3390/pharmaceutics13081274] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Wang ZY, Chen M, Zhu LL, Yu LS, Zeng S, Xiang MX, Zhou Q. Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy. Ther Clin Risk Manag 2015;11:449-67. [PMID: 25848291 DOI: 10.2147/TCRM.S80437] [Cited by in Crossref: 8] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
11 Zhou YT, Yu LS, Zeng S, Huang YW, Xu HM, Zhou Q. Pharmacokinetic drug-drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management. Ther Clin Risk Manag 2014;10:17-26. [PMID: 24379677 DOI: 10.2147/TCRM.S55512] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
12 AbdElhalim MS, Kenawy AS, Demellawy HHE, Azouz AA, Alghanem SS, Al-Otaibi T, Gheith O, ElMonem MA, Afifi MK, Hussein RRS. The impact of omeprazole on mycophenolate pharmacokinetics in kidney transplant recipients. Kidney Res Clin Pract 2020;39:479-86. [PMID: 33214342 DOI: 10.23876/j.krcp.20.059] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Pape E, Michel D, Scala-Bertola J, Schiestel T, Harlé A, Bouchet S, Contet A, Pochon C, Gambier N. Effect of esomeprazole on the oral absorption of dasatinib in a patient with Philadelphia-positive acute lymphoblastic leukemia. Br J Clin Pharmacol 2016;81:1195-6. [PMID: 26833554 DOI: 10.1111/bcp.12895] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chamorro-Petronacci C, García-García A, Lorenzo-Pouso AI, Gómez-García FJ, Padín-Iruegas ME, Gándara-Vila P, Blanco-Carrión A, Pérez-Sayáns M. Management options for low-dose methotrexate-induced oral ulcers: A systematic review. Med Oral Patol Oral Cir Bucal 2019;24:e181-9. [PMID: 30818310 DOI: 10.4317/medoral.22851] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Sienkiewicz-Oleszkiewicz B, Urbańczyk K, Stachowiak M, Rodziewicz A, Zięba A, Kałwak K, Wiela-Hojeńska A. Factors Influencing the Safety and Efficiency of Antifungal Prophylaxis with Posaconazole in Children with Hematological Diseases: From Genetics to Polypharmacotherapy. Indian J Hematol Blood Transfus 2019;35:699-706. [PMID: 31741622 DOI: 10.1007/s12288-019-01134-5] [Reference Citation Analysis]
16 Zhu LL, Zhou Q. The association between gastric acid inhibitors and delirium in geriatric inpatients: implications for clinical practice and research. Clin Interv Aging 2016;11:797-9. [PMID: 27366056 DOI: 10.2147/CIA.S111202] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]